Capricorn Fund Managers »

Enliven Therapeutics shares owned by Capricorn Fund Managers

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Capricorn Fund Managers from 13F filings

Historical chart of Capricorn Fund Managers investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Capricorn Fund Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Capricorn Fund Managers

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 369k 39.20

More positions owned by Capricorn Fund Managers

Carvana Cl A (CVNA)
Bank of America Corporation (BAC)
Zymeworks Del (ZYME)
Axogen (AXGN)
Kkr & Co (KKR)
Envista Hldgs Corp (NVST)
Kingsway Financial Services Com New (KFS)
Adaptive Biotechnologies Cor (ADPT)
Norfolk Southern (NSC)
Beauty Health Company Com Cl A (SKIN)
Primerica Cl A (PRI)
Electronic Arts (EA)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Enliven Therapeutics (ELVN)
Karooooo Ord Shs (KARO)

View all positions for Capricorn Fund Managers

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
BlackRock
Polar Capital Holdings
Commodore Capital
Vestal Point Capital
Vanguard Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
Geode Capital Management
State Street Corporation
Logos Global Management
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics